menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Unfair Treatment of Phase I Clinical Trial Subjects

close
Unfair Treatment of Phase I Clinical Trial Subjects
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Dr. Jonathan Kimmelman, assistant professor of the Biomedical Research unit at McGill University, discusses with host Dr. Maurice Pickard what appears to be a ‘job' that may exploit the underclass in Phase 1 clinical studies. The poor in the studies are less likely to have access to the drugs when approved, which calls the risk/benefit ratio into question. Do for-profit research companies and for-profit Institutional Review Boards provide adequate protection for the rights of the volunteers?

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Dr. Jonathan Kimmelman, assistant professor of the Biomedical Research unit at McGill University, discusses with host Dr. Maurice Pickard what appears to be a ‘job' that may exploit the underclass in Phase 1 clinical studies. The poor in the studies are less likely to have access to the drugs when approved, which calls the risk/benefit ratio into question. Do for-profit research companies and for-profit Institutional Review Boards provide adequate protection for the rights of the volunteers?

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 11/28/20